FDA Approves First Targeted Treatment for Patients with Cholangiocarcinoma, a Cancer of Bile Ducts

FDA has approved Pemazyre (pemigatinib), the first treatment approved for adults with certain types of previously treated, advanced cholangiocarcinoma, a rare form of cancer that forms in bile ducts.

Source: FDA Center for Drug Evaluation and Research - What's New - April 17, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news